U.S. federal trademark · Serial No. 87872108
Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of Sickle cell disease and B-thalassemi; pharmaceutical products and preparations, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.